Results 191 to 200 of about 115,857 (253)

Nurse-Led Patient-Reported Outcome Assessment of Symptom Burden and Quality of Life in Myeloproliferative Neoplasms: An Observational Study. [PDF]

Nurs Open
Berardinelli D, Fava C, Bonuomo V, Grano S, Sinisi F, Ventimiglia I, Costamagna G, Di Giulio P, Campagna S, Ricotti A, Dimonte V.   +10 more
europepmc   +1 more source

Myeloproliferative Neoplasm [PDF]

, 2020
openaire   +1 more source

Obstetric and thrombotic outcomes among pregnant patients with myeloproliferative neoplasms: a propensity score matched real-world analysis. [PDF]

Ann Hematol
Vojjala N, Srungavarapu SR, Nanjareddy S, Kannan MV, Prabhu R, Arsene C, Krishnamoorthy G, Singh V.   +7 more
europepmc   +1 more source

Deep learning differentiates myeloproliferative neoplasms and predicts JAK2 and CALR mutations from bone marrow smears. [PDF]

Ann Hematol
Eckardt JN, Reddy CBV, Hauspurg H, Riechert S, Schmittmann T, Srivastava I, Winter S, Sockel K, Badstübner M, Bornhäuser M, Tiemann M, Middeke JM.   +11 more
europepmc   +1 more source

Modifiable determinants of adherence to tyrosine kinase inhibitors in classical myeloproliferative neoplasms: A mixed-methods systematic review protocol. [PDF]

PLoS One
Inouye FC, Teo V, Clarke J, Georgopoulou S, Freato Gonçalves AMR, de Figueiredo-Pontes LL, Régis Leira Pereira L, Chapman S.   +7 more
europepmc   +1 more source

Risk of Myeloproliferative Neoplasms in Patients With Inflammatory Bowel Disease and Impact on Outcomes: A Multi-Centre Matched Analysis. [PDF]

Aliment Pharmacol Ther
Eldesouki MH, Ibrahim A, Marey MM, Francis FF, Alsakarneh S, Ayala E, Shaukat A, Farraye FA, Hashash JG.   +8 more
europepmc   +1 more source

The PH score: a practical tool for screening myeloproliferative neoplasms in acute portal vein thrombosis. [PDF]

Thromb J
Öztop H, Ada Tak NG, Eren F, Hunutlu FÇ, Ocakoğlu G.   +4 more
europepmc   +1 more source

Efficacy and Safety of Ropeginterferon Alfa-2b in Pregnant Women With Myeloproliferative Neoplasms: Case Series of Three Subtypes and Review. [PDF]

J Korean Med Sci
Kim H, Lee SE, Do YR, Kim SY, Hong J.
europepmc   +1 more source

Beyond the JAK2 mutation: The inflammasome, clonal stability, and the thrombotic niche in myeloproliferative neoplasms. [PDF]

Clin Exp Med
Abdelgawwad El-Sehrawy AAM, Al-Khreisat MJ, Kibriyeva M, Dilbar I, Axmedova F, Mohammed JA, Mishra S, Tailor NK.   +7 more
europepmc   +1 more source

CPX-351 in combination with ruxolitinib for advanced-phase myeloproliferative neoplasms: results of a phase 1 study. [PDF]

Blood Neoplasia
Handa S, Madanat Y, Pugh K, Dvorak-Kornaus K, Zhao Q, Mims A, Koenig K, Srisuwananukorn A, Cook R, Swords R, Borate U.   +10 more
europepmc   +1 more source